Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrave Bison Regulatory News (BBSN)

Share Price Information for Brave Bison (BBSN)

Share Price is delayed by 15 minutes
Get Live Data
97.50    0.00 (0.00%)
Bid:
95.00
Ask:
100.00
Spread: 5.00 (5.263%)
Market Cap: £113.41m
BBSN Live PriceLast checked at - London Stock Exchange

Intraday Brave Bison Share Chart

Director/PDMR Shareholding

29 Apr 2022 13:53

RNS Number : 9158J
Brave Bison Group PLC
29 April 2022
 

29 April 2022

 

Brave Bison Group plc

("Brave Bison" or the "Company")

 

 

Director/PDMR Shareholding

 

 

Brave Bison, the social and digital media company, announces that it has been notified that Philippa Norridge, Chief Financial Officer of the Company, has today purchased 111,111 ordinary shares in the Company at a price of 1.8 pence per ordinary share. Following this purchase, Philippa Norridge is interested in 851,111 ordinary shares in the Company, representing approximately 0.1 per cent. of the Company's issued ordinary share capital.

 

The notification below, made in accordance with the UK Market Abuse Regulation, provides further details.

 

For further information please contact:

 

Brave Bison Group plc

Oliver Green, Executive Chairman via Cenkos

Theo Green, Chief Growth Officer

Philippa Norridge, Chief Financial Officer

 

Cenkos Securities plc Tel: +44 (0)20 7397 8900

Nominated Adviser & Broker

Nicholas Wells

Ben Jeynes

 

 

 

 

 1

Details of the person discharging managerial responsibilities / person closely associated (PCA)

a)

Name

Philippa Norridge

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b) 

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Brave Bison Group plc

b)

LEI

213800BEII7EWIN8X308

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

ordinary shares of 0.1p each

 

 

Identification code (ISIN) for Brave Bison Group plc ordinary shares: GB00BF8HJ774

 

b)

Nature of the transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

1.8 pence

 

 

111,111

 

d)

Aggregated information

 

- Aggregated volume

- Price

 

N/A - single transaction

e)

Date of the transaction

29 April 2022

f)

Place of the transaction

AIMX

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHLKLFLLZLEBBF
Date   Source Headline
22nd May 20178:12 amRNSRule 2.9 Announcement
19th May 20173:33 pmRNSForm 8.3 - Brave Bison Group Plc
19th May 20173:28 pmRNSForm 8.5 (EPT/RI) - Replacement
19th May 20173:24 pmRNSForm 8.3 - Brave Bison Group Plc
19th May 201712:21 pmBUSForm 8 (OPD) - Brave Bison Group Plc
19th May 201711:56 amRNSForm 8.5 (EPT/RI)
19th May 201711:54 amRNSForm 8.5 (EPT/RI) - Brave Bison
18th May 20171:03 pmRNSReplacement - Statement re press speculation
18th May 201711:45 amRNSResponse to announcement by Brave Bison Group plc
18th May 201711:19 amRNSStatement re press speculation
8th May 20177:00 amRNSAnnual Report and Notice of AGM
24th Apr 20177:00 amRNSStrategic relationship with PGA TOUR
5th Apr 20177:00 amRNSLaunch of Rebel FC - YouTube Football Super-Team
3rd Apr 20177:00 amRNSBrave Bison wins Shell YouTube channel management
31st Mar 20177:01 amRNSBrave Bison Opens Social Video Broadcast Studio
31st Mar 20177:00 amRNSFinal Results
1st Mar 20179:47 amRNSCorrection - Issue of Equity
1st Mar 20177:00 amRNSIssue of Equity
17th Feb 201710:00 amRNSTrading Update
30th Jan 20177:00 amRNSFurther re Directorate
11th Jan 20179:20 amRNSCorrection - Further re Directorate Change
11th Jan 20179:00 amRNSFurther re Directorate Change
9th Jan 20177:00 amRNSDirectorate Change
26th Oct 201611:57 amRNSLock-in and Orderly Market Agreement
24th Oct 20167:00 amRNSDirectorate Change
27th Sep 20167:00 amRNSDirectorate Change
22nd Sep 20167:00 amRNSIssue of Equity
31st Aug 20167:00 amRNSHalf-year Report
26th Jul 20167:00 amRNSTrading Update & Notice of Interim Results
25th Jul 201612:04 pmRNSBBSN appoints Will Pyne as Chief Creative Officer
21st Jul 20167:00 amRNSIssue of Equity
27th May 20167:00 amRNSDirectorate change
20th May 20167:00 amRNSDirectorate Change
10th May 20167:01 amRNSRightster officially becomes Brave Bison
10th May 20167:00 amRNSResult of AGM
9th May 20167:00 amRNSAGM Statement
13th Apr 20167:00 amRNSFinal Results
29th Mar 20167:00 amRNSIssue of Equity
9th Feb 201611:50 amRNSHolding(s) in Company
8th Feb 201611:16 amRNSHolding(s) in Company
8th Feb 201611:12 amRNSDirector/PDMR Shareholding
2nd Feb 201612:48 pmRNSHolding(s) in Company
12th Jan 20167:00 amRNSPartnership with Paramount Pictures
6th Jan 201612:04 pmRNSResult of General Meeting
18th Dec 20154:27 pmRNSProposed Placing and Notice of General Meeting
27th Nov 20157:00 amRNSStrategic review update and end of Offer Period
25th Nov 20157:00 amRNSForm 8.3 - Rightster Group Amendment
20th Nov 20152:12 pmRNSForm 8.3 - Rightster Group Amendment RNS 9268D
20th Nov 20151:30 pmRNSSir Robin Miller - Form 8 (DD) - [Rightster Group]
20th Nov 20151:29 pmRNSPatrick Walker - Form 8 (DD) - [Rightster Group]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.